<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00812578</url>
  </required_header>
  <id_info>
    <org_study_id>UKO-1006-2008</org_study_id>
    <nct_id>NCT00812578</nct_id>
  </id_info>
  <brief_title>Metabolic Effects of Vitamin D in Patients With Type 2 Diabetes</brief_title>
  <acronym>ProjectD</acronym>
  <official_title>Metabolic Effects of Vitamin D in Patients With Type 2 Diabetes - a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regionshospitalet Silkeborg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to examine the effect on metabolic parameters after 12 weeks of
      treatment with high dose vitamin D in patients with type 2 diabetes and vitamin D
      insufficiency.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is increasing evidence that vitamin D affects the risk of diabetes. The role of vitamin
      D in type 2 diabetes is suggested by cross sectional studies, where an inverse association
      between vitamin D status and the development of type 2 diabetes has been found. Moreover
      supplementation with calcium and vitamin D may attenuate increases in glycemia and insulin
      resistance in healthy older adults with IFG. However further research is needed to confirm
      these findings and to determine possible mechanisms of the preventive effect from vitamin D
      against diabetes. The aim of this study is to examine the effect on metabolic parameters such
      as glycemic control, lipid status, inflammatory markers, insulin resistance and insulin
      secretion in patients with type 2 diabetes and vitamin D insufficiency before and after a
      12-week period of treatment with high doses of vitamin D.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin secretion and insulin resistance</measure>
    <time_frame>6 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glycemic control, lipid status, inflammatory markers, BMD</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>Vitamin D Insufficiency</condition>
  <arm_group>
    <arm_group_label>Cholecalciferol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol</intervention_name>
    <description>8 tablets equivalent to 280 micrograms for 2 weeks and 4 tablets equivalent to 140 micrograms for 10 weeks</description>
    <arm_group_label>Cholecalciferol</arm_group_label>
    <arm_group_label>Placebo pill</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent

          -  Type 2 diabetes

          -  Patients of Danish extraction

          -  Vitamin D insufficiency (1,25OHvitD &lt; 50 nmol/l)

        Exclusion Criteria:

          -  Nephropathy (Urea &gt; 12 mmol/l)

          -  S-calcium &gt; 2,52 mmol/L

          -  Primary hyperparathyroidism

          -  Serious disease

          -  Malabsorption

          -  Sarcoidosis

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lotte Oeskov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Department, Silkeborg Hospital, Falkevej 1-3, 8600 Silkeborg, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Research Unit, Medical Department M, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2008</study_first_submitted>
  <study_first_submitted_qc>December 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2008</study_first_posted>
  <last_update_submitted>July 9, 2010</last_update_submitted>
  <last_update_submitted_qc>July 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 12, 2010</last_update_posted>
  <responsible_party>
    <name_title>MD, Med. Sci. Lotte Oerskov</name_title>
    <organization>Medical Department, Silkeborg Hospital</organization>
  </responsible_party>
  <keyword>Type 2 diabetes</keyword>
  <keyword>Vitamin D insufficiency</keyword>
  <keyword>Insulin secretion</keyword>
  <keyword>Insulin sensitivity</keyword>
  <keyword>Pulsatility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

